Abstract:Background: Mutations of the isocitrate dehydrogenase 1 and 2 gene (IDH1/2) were initially thought to enhance cancer cell survival and proliferation by promoting the Warburg effect. However, recent experimental data have shown that production of 2-hydroxyglutarate by IDH mutant cells promotes hypoxia-inducible factor (HIF)1α degradation and, by doing so, may have unexpected metabolic effects. Methods: We used human glioma tissues and derived brain tumor stem cells (BTSCs) to study the expression of HIF1α target genes in IDH mutant ((mt)) and IDH wild-type ((wt)) tumors. Focusing thereafter on the major glycolytic enzyme, lactate dehydrogenase A (LDHA), we used standard molecular methods and pyrosequencing-based DNA methylation analysis to identify mechanisms by which LDHA expression was regulated in human gliomas. Results: We found that HIF1α-responsive genes, including many essential for glycolysis (SLC2A1, PDK1, LDHA, SLC16A3), were underexpressed in IDH(mt) gliomas and/or derived BTSCs. We then demonstrated that LDHA was silenced in IDH(mt) derived BTSCs, including those that did not retain the mutant IDH1 allele (mIDH(wt)), matched BTSC xenografts, and parental glioma tissues. Silencing of LDHA was associated with increased methylation of the LDHA promoter, as was ectopic expression of mutant IDH1 in immortalized human astrocytes. Furthermore, in a search of The Cancer Genome Atlas, we found low expression and high methylation of LDHA in IDH(mt) glioblastomas. Conclusion: To our knowledge, this is the first demonstration of downregulation of LDHA in cancer. Although unexpected findings, silencing of LDHA and downregulation of several other glycolysis essential genes raise the intriguing possibility that IDH(mt) gliomas have limited glycolytic capacity, which may contribute to their slow growth and better prognosis.

Knockdown of LDHA Inhibits Growth and EMT of Glioma Cells

LDHB Promotes the Growth of Glioma Cells via PDK1/Akt/GSK3p Pathway

Silencing LDHA Inhibits Proliferation, Induces Apoptosis and Increases Chemosensitivity to Temozolomide in Glioma Cells

Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells

Knockdown Of Lactate Dehydrogenase A Suppresses Tumor Growth And Metastasis Of Human Hepatocellular Carcinoma

Knockdown of Hdac1 Expression Suppresses Invasion and Induces Apoptosis in Glioma Cells

[Effect of LDHA Knockdown by Sirna on Migration and Invasion of ErbB2 Overexpressing Breast Cancer Cell Line].

Inhibition of TGF-β1-induced epithelial-mesenchymal transition in gliomas by DMC-HA

LDHA Promotes Tumor Metastasis by Facilitating Epithelial-Mesenchymal Transition in Renal Cell Carcinoma

Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.

Inhibition of LDHA Deliver Potential Anticancer Performance in Renal Cell Carcinoma.

Inhibition of LDHA suppresses tumor progression in prostate cancer

LDHA is Necessary for the Tumorigenicity of Esophageal Squamous Cell Carcinoma.

Downregulation of ARHGDIA Contributes to Human Glioma Progression Through Activation of Rho GTPase Signaling Pathway

LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial–Mesenchymal Transition

Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.

LDH-A Promotes Malignant Behavior Via Activation of Epithelial-to-mesenchymal Transition in Lung Adenocarcinoma

Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.

LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression

Lactate dehydrogenase A silencing in IDH mutant gliomas

Expression and its significance of lactate dehydrogenase-A subunit (LDH-A) in human gliomas